COVID-19 and the Issue of Affordable Access to Innovative Health Technologies: An Analysis of Compulsory Licensing of Patents as a Policy Option-Reference-Cited by-同舟云学术

COVID-19 and the Issue of Affordable Access to Innovative Health Technologies: An Analysis of Compulsory Licensing of Patents as a Policy Option

Published:2022 Issue: Volume: Page:265-294
ISSN:2512-1294
Container-title:Law and Economics of the Coronavirus Crisis
language:
Short-container-title:

Author:

Abbas Muhammad Zaheer

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-030-95876-3_10

Reference84 articles.

1. Abbas MZ (2013) Pros and cons of compulsory licensing: an analysis of arguments. Int J Soc Sci Human 3(3):254–258. https://doi.org/10.7763/ijssh.2013.v3.239 (last access 21 September 2021)

2. Abbas MZ (2017) The issue of undeserving patent monopolies in innovation-based businesses and implications thereof for underprivileged consumers. Bus Manag Rev 9(1):3–4

3. Abbas MZ (2020a) Strategic use of patent opposition safeguard to improve equitable access to innovative health technologies: a case study of CAR T-cell therapy Kymriah. Global Public Health 0. https://doi.org/10.1080/17441692.2020.1825769 (last access 21 September 2021)

4. Abbas MZ (2020b) COVID-19 and the global public health: tiered pricing of pharmaceutical drugs as a price-reducing policy tool. J Generic Med Bus J Generic Med Sect 174113432096314. https://doi.org/10.1177/1741134320963146 (last access 21 September 2021)

5. Abbas MZ (2020c) Conflicting interests, competing perspectives and policy incoherence: COVID-19 highlights the significance of the United Nations high-level panel report on access to medicines. Aust Intell Prop J 31

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Compulsory Licences During the COVID-19 Pandemic: A European and International Perspective;The European Union and the Evolving Architectures of International Economic Agreements;2023